TY - JOUR
T1 - White matter lesion location correlates with disability in relapsing multiple sclerosis
AU - Gaetano, Laura
AU - Magnusson, Baldur
AU - Kindalova, Petya
AU - Tomic, Davorka
AU - Silva, Diego
AU - Altermatt, Anna
AU - Magon, Stefano
AU - Müller-Lenke, Nicole
AU - Radue, Ernst Wilhelm
AU - Leppert, David
AU - Kappos, Ludwig
AU - Wuerfel, Jens
AU - Häring, Dieter A.
AU - Sprenger, Till
N1 - Publisher Copyright:
© The Author(s) 2020.
PY - 2020
Y1 - 2020
N2 - Background: Lesion location is a prognostic factor of disease progression and disability accrual. Objective: To investigate lesion formation in 11 brain regions, assess correlation between lesion location and physical and cognitive disability measures and investigate treatment effects by region. Methods: In 2355 relapsing–remitting multiple sclerosis patients from the FREEDOMS and FREEDOMS II studies, we extracted T2-weighted lesion number, volume and density for each brain region; we investigated the (Spearman) correlation in lesion formation between brain regions, studied association between location and disability (at baseline and change over 2 years) using linear/logistic regression and assessed the regional effects of fingolimod versus placebo in negative binomial models. Results: At baseline, the majority of lesions were found in the supratentorial brain. New and enlarging lesions over 24 months developed mainly in the frontal and sublobar regions and were substantially correlated to pre-existing lesions at baseline in the supratentorial brain (p = 0.37–0.52), less so infratentorially (p = −0.04–0.23). High sublobar lesion density was consistently and significantly associated with most disability measures at baseline and worsening of physical disability over 24 months. The treatment effect of fingolimod 0.5 mg was consistent across the investigated areas and tracts. Conclusion: These results highlight the role of sublobar lesions for the accrual of disability in relapsing–remitting multiple sclerosis.
AB - Background: Lesion location is a prognostic factor of disease progression and disability accrual. Objective: To investigate lesion formation in 11 brain regions, assess correlation between lesion location and physical and cognitive disability measures and investigate treatment effects by region. Methods: In 2355 relapsing–remitting multiple sclerosis patients from the FREEDOMS and FREEDOMS II studies, we extracted T2-weighted lesion number, volume and density for each brain region; we investigated the (Spearman) correlation in lesion formation between brain regions, studied association between location and disability (at baseline and change over 2 years) using linear/logistic regression and assessed the regional effects of fingolimod versus placebo in negative binomial models. Results: At baseline, the majority of lesions were found in the supratentorial brain. New and enlarging lesions over 24 months developed mainly in the frontal and sublobar regions and were substantially correlated to pre-existing lesions at baseline in the supratentorial brain (p = 0.37–0.52), less so infratentorially (p = −0.04–0.23). High sublobar lesion density was consistently and significantly associated with most disability measures at baseline and worsening of physical disability over 24 months. The treatment effect of fingolimod 0.5 mg was consistent across the investigated areas and tracts. Conclusion: These results highlight the role of sublobar lesions for the accrual of disability in relapsing–remitting multiple sclerosis.
KW - White matter lesion
KW - demyelination
KW - disability
KW - fingolimod
KW - frontal lobe
KW - multiple sclerosis and neuroinflammation
KW - multiple sclerosis: imaging
UR - http://www.scopus.com/inward/record.url?scp=85102091621&partnerID=8YFLogxK
U2 - 10.1177/2055217320906844
DO - 10.1177/2055217320906844
M3 - Article
AN - SCOPUS:85102091621
SN - 2055-2173
VL - 6
JO - Multiple Sclerosis Journal - Experimental, Translational and Clinical
JF - Multiple Sclerosis Journal - Experimental, Translational and Clinical
IS - 1
ER -